Skip to main content
# Title Department Research Year
461 Optimization of a sensitive and robust strategy for micellar electrokinetic chromatographic analysis of sofosbuvir in combination with its co-formulated hepatitis C antiviral drugs Department of Pharmaceutical Analytical Chemistry 2020
462 Design, Synthesis and Biological Evaluation of New HDAC1 and HDAC2 Inhibitors Endowed with Ligustrazine as a Novel Cap Moiety Department of Pharmaceutical Organic Chemistry 2020
463 Click chemistry synthesis, biological evaluation and docking study of some novel 2′-hydroxychalcone-triazole hybrids as potent anti-inflammatory agents. Department of Pharmaceutical Organic Chemistry 2020
464 Gene Therapy for Hepatocellular Carcinoma: Highlighting the Journey from Theory to Clinical Applications Department of Pharmaceutics 2020
465 Facile fabrication of a novel 3D rose like lanthanum doped zirconia decorated reduced graphene oxide nanosheets: An efficient electro-catalyst for electrochemical reduction of futuristic anti-cancer drug salinomycin during pharmacokinetic study Department of Pharmaceutical Analytical Chemistry 2020
466 Design and Synthesis of Novel Isatin-Based derivatives Targeting Cell Cycle Checkpoint Pathways as Potential Anticancer Agents Department of Medicinal Chemistry 2020
467 CK2 Inhibition, Lipophilicity and Anticancer Activity of New N1 Versus N2-Substituted Tetrabromobenzotriazole Regioisomers Department of Pharmaceutical Organic Chemistry 2020
468 Design of “Turn On” fluorometric nanoprobe based on nitrogen doped graphene quantum dots modified with β-cyclodextrin and vitamin B6 cofactor for selective sensing of dopamine in human serum Department of Pharmaceutical Analytical Chemistry 2020
469 Lipid Nanoparticles for Cell-Specific in Vivo Targeted Delivery of Nucleic Acids Department of Industrial Pharmacy 2020
470 Biocatalytic microgels (μ-Gelzymes): synthesis, concepts, and emerging applications Department of Pharmacognosy 2020